
The Drilling Company Maersk Drilling said Monday that after the UK Competition and Markets Authority raised concerns over its planned acquisition by Noble Corp, the companies now plan to offer remedies.
Noble agreed to buy Maersk Drilling last November in an all-share deal under which shareholders of each company would own 50% of the combined group. However, last month UK regulators said the deal could increase operating costs for oil-and-gas producers in the U.K. and it would refer the deal for further review, unless the companies offer a solution.
Related: UK Watchdog Is Concerned Over Noble & Maersk Drilling Deal
In a statement Monday, Maersk Drilling said Noble plans to offer to divest certain jackup rigs currently located in the North Sea as it seeks to obtain conditional antitrust clearance from the U.K. CMA in Phase 1 of the merger control process.
The rigs concerned are the Noble Hans Deul, Noble Sam Hartley, Noble Sam Turner, Noble Houston Colbert, and either the Maersk Innovator or the Noble Lloyd Noble.
If the companies are able to obtain a conditional Phase 1 antitrust clearance from the U.K. CMA, the business combination is expected to close in mid-2022, it said.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
House Budget Bill’s Moratorium on State AI Laws Could Undo A Range of Tech Regs, Critics Say
May 14, 2025 by
CPI
Microsoft Nears EU Antitrust Resolution Over Teams Bundling, Sources Say
May 14, 2025 by
CPI
CMA Investigates Aviva’s £3.6B Acquisition of Direct Line Group
May 14, 2025 by
CPI
Google Urges Texas Judge to Disregard Virginia Antitrust Ruling
May 14, 2025 by
CPI
Anthropic Ordered to Respond After AI Allegedly Fabricates Citation in Legal Filing
May 14, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas